Company news
Alar Pharmaceuticals Inc news in 2026
Alar Pharmaceuticals Inc's news releases, calls and decks from 2026, newest first.
Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression
April 6, 2026
Alar Announced Buprenorphine Injectable, ALA-1000, Demonstrated Long-Term Efficacy and Favorable Safety Profile in Canine Osteoarthritis Pain Management
March 16, 2026